[ASCO]
Phase I/II Study of Bavdegalutamide, a Proteolysis-Targeting Chimera Androgen Receptor Degrader, in Metastatic Castration-Resistant Prostate Cancer
文献作者:Xin Gao; Benjamin Garmezy; Jacqueline Vuky; John Shen; Oliver Sartor; Cora N. Sternberg; Robert Dreicer; Maha Hussain; Arash Rezazadeh Kalebasty; Ivor J. Percent; Elisabeth I. Heath; Sunil Gandhi; Benjamin L. Maughan; Xin Zhi; Sean Landrette; Jiachang Gong; Diane Healey; Janaki Parameswaran; Daniel P. Petrylak